CNBCImmunomedics shares double after Gilead agrees to buy the cancer drugmaker in $21 billion dealSep 13, 2020Berkeley Lovelace, Emma Newburger & Berkeley Lovelace Jr.By Berkeley Lovelace, Emma Newburger & Berkeley Lovelace Jr.more_vert